Mar 16, 2023 07:05AM
May 13, 2022 07:05AM
Jan 12, 2022 04:15PM
Dec 22, 2021 07:05AM
Dec 22, 2021 07:05AM
Nov 10, 2021 05:05PM
Sep 1, 2021 07:05AM IMV Inc. to Present at Three Investor Conferences in September
Aug 11, 2021 07:05AM
Aug 10, 2021 07:11AM
Aug 4, 2021 08:30AM
Jun 18, 2021 04:05PM
Jun 8, 2021 07:05AM
May 12, 2021 07:05AM
May 10, 2021 07:05AM IMV’s Lead Immunotherapy to be Investigated in Breast Cancer
Apr 29, 2021 07:05AM
Apr 7, 2021 07:10AM
Apr 7, 2021 07:05AM
Mar 17, 2021 07:05AM
Mar 8, 2021 07:05AM
Mar 1, 2021 07:05AM
Jan 4, 2021 07:05AM IMV to Participate in Two Upcoming Investor Events
Dec 6, 2020 08:15AM
Dec 3, 2020 07:11AM
Dec 3, 2020 07:10AM
Nov 13, 2020 07:05AM
Nov 12, 2020 07:05AM
Nov 9, 2020 05:05PM
Nov 9, 2020 08:07AM IMV's T (IMV) Cell Therapy Demonstrates 86% Objective Response Rate in Combination with Merck’s Keytruda® in PD-L1 Positive Patients with r/r DLBCL
Nov 9, 2020 08:00AM
Nov 4, 2020 05:05PM
Oct 15, 2020 07:05AM
Sep 16, 2020 07:05AM
Aug 26, 2020 07:05AM
Aug 12, 2020 07:05AM
Aug 3, 2020 07:05AM IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020
Jul 29, 2020 07:05AM
Jul 20, 2020 07:07AM
Jul 20, 2020 07:05AM
Jul 14, 2020 09:24AM
Jun 15, 2020 07:05AM
May 29, 2020 08:05AM
Mar 30, 2020 05:05PM IMV Inc. Announces Fourth Quarter and Full Year 2019 Financial and Operational Results
Mar 30, 2020 07:08AM
Mar 30, 2020 07:05AM
Mar 25, 2020 07:05AM
Feb 25, 2020 05:52AM
Feb 25, 2020 03:05AM
Feb 20, 2020 07:05AM
Feb 4, 2020 07:05AM Clinical Translational Data Supporting DPX-Survivac Mechanism of Action to be Presented at 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Jan 24, 2020 07:05AM

322,240 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All